EDWARDS LIFESCIENCES CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.89 USD | +0.99% |
|
+0.49% | +15.27% |
| 23/05 | Some of the biggest splits in Corporate America | RE |
| 22/05 | Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 | MT |
Chart calendar Edwards Lifesciences Corporation
aa.YYvhv2VNNvRvve5H-IVZkxVSq0UrLYzvphr6DeiaXoo.VOOJ-B8MUdkW2KVqvsEc5EEN9CAYXryO_Cm8R5__C7IL6In7UnpHoQn_1g~fd77cdb394cb098b8915f6b39d01aa21
Upcoming events on Edwards Lifesciences Corporation
Past events on Edwards Lifesciences Corporation
| 07/05/2024 10:30 pm | Annual General Meeting |
| 26/04/2024 02:30 am | Q1 2024 Earnings Call |
| 26/04/2024 01:45 am | Q1 2024 Earnings Release |
| 05/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 07/02/2024 03:30 am | Q4 2023 Earnings Call |
| 07/02/2024 02:45 am | Q4 2023 Earnings Release |
| 10/01/2024 12:45 am | JPMorgan Healthcare Conference |
| 07/12/2023 10:00 pm | Investor Conference |
| 27/10/2023 03:00 am | Analyst & Investor Meeting - TMTT Q&A Session at TCT |
| 26/10/2023 | Transcatheter Cardiovascular Therapeutics Scientific Symposium |
| 26/10/2023 02:30 am | Q3 2023 Earnings Call |
| 26/10/2023 01:45 am | Q3 2023 Earnings Release |
| 25/10/2023 06:30 am | Analyst & Investor Meeting - TAVR Q&A Session at TCT |
| 07/09/2023 08:30 pm | Wells Fargo Healthcare Conference |
| 27/07/2023 02:30 am | Q2 2023 Earnings Call |
| 27/07/2023 01:45 am | Q2 2023 Earnings Release |
| 17/05/2023 | American Association for Thoracic Surgery Meeting |
| 11/05/2023 10:30 pm | Annual General Meeting |
| 07/05/2023 | American Association for Thoracic Surgery Meeting |
| 27/04/2023 02:30 am | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4 348 4 316 0.73% | 4 386 4 385 0.02% | 5 233 5 255 -0.43% | 5 382 5 365 0.32% | 6 005 5 972 0.55% | 6 560 |
|
EBITDA Million USD | Released Forecast Spread | 1 406 1 425 -1.36% | 1 429 1 444 -1% | 1 729 1 766 -2.07% | 1 936 1 942 -0.31% | 1 879 1 904 -1.34% | 2 061 |
|
EBIT Million USD | Released Forecast Spread | 1 316 1 328 -0.86% | 1 322 1 334 -0.9% | 1 595 1 622 -1.73% | 1 797 1 789 0.4% | 1 734 1 754 -1.15% | 1 902 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 167 1 180 -1.14% | 917 903 1.51% | 1 702 1 585 7.4% | 1 767 1 740 1.55% | 1 598 1 658 -3.62% | 1 890 |
|
Net income Million USD | Released Forecast Spread | 1 047 1 031 1.59% | 823 819 0.5% | 1 503 1 437 4.63% | 1 522 1 498 1.56% | 1 402 1 399 0.22% | 1 613 |
|
EPS USD | Released Forecast Spread | 1,64 1,63 0.61% | 1,30 1,32 -1.82% | 2,38 2,30 3.3% | 2,44 2,39 2.16% | 2,30 2,29 0.34% | 2,64 |
| Announcement Date | 30/01/20 | 27/01/21 | 26/01/22 | 31/01/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 341 1 311 2.29% | 1 374 1 399 -1.83% | 1 319 1 333 -1.03% | 1 348 1 329 1.43% | 1 460 1 394 4.69% | 1 530 1 505 1.67% | 1 481 1 480 0.05% | 1 534 1 499 2.34% | 1 598 1 572 1.68% | 1 655 | 1 622 | 1 686 | 1 743 | 1 809 |
|
EBITDA Million USD | Released Forecast Spread | 479 452 6.08% | 480 496 -3.14% | 493 487 1.12% | 484 481 0.7% | 469 471 -0.4% | 486 495 -1.88% | 459 458 0.08% | 465 489 -4.95% | 478 494 -3.38% | 523 | 515 | 543 | 558 | 586 |
|
EBIT Million USD | Released Forecast Spread | 445 413 7.57% | 446 460 -3.13% | 457 453 0.96% | 449 443 1.21% | 434 434 0.02% | 450 456 -1.38% | 422 419 0.64% | 428 446 -3.95% | 439 450 -2.35% | 479 | 476 | 504 | 514 | 545 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 436 397 9.9% | 465 435 6.79% | 407 436 -6.64% | 459 436 5.36% | 399 431 -7.62% | 339 449 -24.63% | 439 425 3.25% | 422 445 -5.24% | 409 450 -9.07% | 490 | 484 | 509 | 525 | 558 |
|
Net income Million USD | Released Forecast Spread | 374 343 8.94% | 406 389 4.52% | 344 383 -10.36% | 398 375 6.2% | 341 371 -8.1% | 307 375 -18.06% | 385 345 11.45% | 370 385 -3.97% | 352 379 -7.07% | 411 | 406 | 429 | 435 | 466 |
|
EPS USD | Released Forecast Spread | 0,59 0,56 5.36% | 0,65 0,62 5.69% | 0,55 0,61 -10.33% | 0,65 0,60 8.33% | 0,56 0,60 -7.24% | 0,50 0,61 -17.89% | 0,63 0,56 12.17% | 0,61 0,63 -3.13% | 0,58 0,63 -7.23% | 0,68 | 0,67 | 0,71 | 0,72 | 0,77 |
| Announcement Date | 26/04/22 | 28/07/22 | 27/10/22 | 31/01/23 | 26/04/23 | 26/07/23 | 25/10/23 | 06/02/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for Edwards Lifesciences Corporation
| 30/05/2024 01:35 am | AGILENT TECHNOLOGIES, INC.: Q2 2024 Earnings Release |
| 15/05/2024 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
| 13/05/2024 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
| 10/05/2024 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 09/05/2024 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 01:35 am | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 09/05/2024 01:31 am | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 08/05/2024 10:30 am | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
| 08/05/2024 | CLASSYS INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:30 am | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EW Stock
- Calendar Edwards Lifesciences Corporation
